Zydus Lifesciences Ltd (ZYDUSLIFE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 290229,
    "name": "Zydus Lifesci.",
    "stock_name": "Zydus Lifesci.",
    "full_name": "Zydus Lifesciences Ltd",
    "name_url": "stocks-analysis/zydus-lifesci",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "864.25",
    "chg": 0.8,
    "chgp": "0.09%",
    "dir": 1,
    "prev_price": "863.45",
    "mcapval": "84,584.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 532321,
    "symbol": "ZYDUSLIFE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE010B01027",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "10.6 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/zydus-lifesci-290229-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Zydus Lifesciences Sees Sharp Open Interest Surge Amid Bearish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-sharp-open-interest-surge-amid-bearish-momentum-3929323",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ZydusLifescienc_oi_spurts_by_underlying_3929323.png",
        "date": "2026-04-01 15:00:08",
        "description": "Zydus Lifesciences Ltd has witnessed a significant 15.14% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with declining prices and rising delivery volumes, suggests a complex interplay of investor positioning and potential directional bets in the pharmaceuticals sector."
      },
      {
        "title": "Zydus Lifesciences Sees Sharp Open Interest Surge Amid Bearish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-sharp-open-interest-surge-amid-bearish-momentum-3929249",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ZydusLifescienc_oi_spurts_by_underlying_3929249.png",
        "date": "2026-04-01 14:00:08",
        "description": "Zydus Lifesciences Ltd has witnessed a notable 11.56% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with declining prices and rising delivery volumes, suggests a shift in market positioning that may indicate growing bearish bets among traders."
      },
      {
        "title": "Zydus Lifesciences Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-sharp-open-interest-surge-amid-mixed-market-signals-3929209",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ZydusLifescienc_oi_spurts_by_underlying_3929209.png",
        "date": "2026-04-01 13:00:07",
        "description": "Zydus Lifesciences Ltd has witnessed a notable 10.08% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest 0.60% gain in the stock price, the pharmaceutical company’s futures and options volumes suggest a complex interplay of directional bets amid broader sector underperformance."
      },
      {
        "title": "Zydus Lifesciences Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zydus-lifesciences-ltd-is-rated-sell-by-marketsmojo-3928523",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ZydusLifescienc_mojoScore_3928523.png",
        "date": "2026-04-01 10:10:03",
        "description": "Zydus Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Zydus Lifesciences Ltd Technical Momentum Shifts Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-ltd-technical-momentum-shifts-amid-bearish-signals-3923230",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ZydusLifescienc_technicaldot_3923230.png",
        "date": "2026-03-30 08:00:29",
        "description": "Zydus Lifesciences Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a modest decline in the stock price, the pharmaceutical mid-cap continues to demonstrate resilience relative to broader market benchmarks, though caution is warranted given the mixed signals from moving averages, MACD, and other momentum oscillators."
      },
      {
        "title": "Zydus Lifesciences Sees Notable Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-notable-open-interest-surge-amid-mixed-market-signals-3920040",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ZydusLifescienc_oi_spurts_by_underlying_3920040.png",
        "date": "2026-03-27 15:00:17",
        "description": "Zydus Lifesciences Ltd has witnessed a notable 12.5% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest decline in the stock price, the surge in open interest alongside rising volumes suggests evolving directional bets within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Zydus Lifesciences Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-sharp-open-interest-surge-amid-mixed-market-signals-3919832",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ZydusLifescienc_oi_spurts_by_underlying_3919832.png",
        "date": "2026-03-27 14:00:15",
        "description": "Zydus Lifesciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 13.15% increase in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a marginal day-on-day price decline of 0.06%, the stock outperformed its sector by 0.32% and remained resilient against broader market weakness, as the Sensex fell 1.57% on 27 Mar 2026."
      },
      {
        "title": "Zydus Lifesciences Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zydus-lifesciences-ltd-is-rated-sell-by-marketsmojo-3905043",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ZydusLifescienc_mojoScore_3905043.png",
        "date": "2026-03-21 10:10:03",
        "description": "Zydus Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Zydus Lifesciences Ltd Opens with Sharp Gap Down Amid Market Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-ltd-opens-with-sharp-gap-down-amid-market-concerns-3893904",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ZydusLifescienc_gapdown_3893904.png",
        "date": "2026-03-16 12:10:11",
        "description": "Zydus Lifesciences Ltd commenced trading today with a pronounced gap down, opening 5.84% lower than its previous close, reflecting heightened market apprehension following recent developments. The stock’s weak start adds to a sequence of declines amid broader sector pressures."
      }
    ],
    "total": 627,
    "sid": "290229",
    "stock_news_url": "https://www.marketsmojo.com/news/zydus-lifesciences-290229"
  },
  "announcements": [
    {
      "caption": "Receipt Of Demand Order-In-Original From Assistant Commissioner Central Goods And Services Tax Division-Ambala",
      "datetime": "01-Apr-2026",
      "details": "Receipt of Demand Original-In-Original from Assistant Commissioner Central Goods and Services Tax Division - Ambala",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "31-Mar-2026",
      "details": "Transition from Senior Management",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2026",
      "details": "Intimation of trading window closure",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Lifesciences Ltd has declared <strong>1100%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Lifesciences Ltd has announced <strong>1:5</strong> stock split, ex-date: 06 Oct 15",
          "dt": "2015-10-06",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Lifesciences Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 05 Apr 10",
          "dt": "2010-04-05",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Zydus Lifesciences Sees Sharp Open Interest Surge Amid Bearish Momentum

2026-04-01 15:00:08

Zydus Lifesciences Ltd has witnessed a significant 15.14% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with declining prices and rising delivery volumes, suggests a complex interplay of investor positioning and potential directional bets in the pharmaceuticals sector.

Read full news article

Zydus Lifesciences Sees Sharp Open Interest Surge Amid Bearish Momentum

2026-04-01 14:00:08

Zydus Lifesciences Ltd has witnessed a notable 11.56% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with declining prices and rising delivery volumes, suggests a shift in market positioning that may indicate growing bearish bets among traders.

Read full news article

Zydus Lifesciences Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-04-01 13:00:07

Zydus Lifesciences Ltd has witnessed a notable 10.08% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest 0.60% gain in the stock price, the pharmaceutical company’s futures and options volumes suggest a complex interplay of directional bets amid broader sector underperformance.

Read full news article

Zydus Lifesciences Ltd is Rated Sell by MarketsMOJO

2026-04-01 10:10:03

Zydus Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Zydus Lifesciences Ltd Technical Momentum Shifts Amid Bearish Signals

2026-03-30 08:00:29

Zydus Lifesciences Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a modest decline in the stock price, the pharmaceutical mid-cap continues to demonstrate resilience relative to broader market benchmarks, though caution is warranted given the mixed signals from moving averages, MACD, and other momentum oscillators.

Read full news article

Zydus Lifesciences Sees Notable Open Interest Surge Amid Mixed Market Signals

2026-03-27 15:00:17

Zydus Lifesciences Ltd has witnessed a notable 12.5% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest decline in the stock price, the surge in open interest alongside rising volumes suggests evolving directional bets within the Pharmaceuticals & Biotechnology sector.

Read full news article

Zydus Lifesciences Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-03-27 14:00:15

Zydus Lifesciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 13.15% increase in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a marginal day-on-day price decline of 0.06%, the stock outperformed its sector by 0.32% and remained resilient against broader market weakness, as the Sensex fell 1.57% on 27 Mar 2026.

Read full news article

Zydus Lifesciences Ltd is Rated Sell by MarketsMOJO

2026-03-21 10:10:03

Zydus Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Zydus Lifesciences Ltd Opens with Sharp Gap Down Amid Market Concerns

2026-03-16 12:10:11

Zydus Lifesciences Ltd commenced trading today with a pronounced gap down, opening 5.84% lower than its previous close, reflecting heightened market apprehension following recent developments. The stock’s weak start adds to a sequence of declines amid broader sector pressures.

Read full news article

View All News